Culture

Researchers identify drugs with fewest side-effects for treating irritable bowel syndrome

Los Angeles (Embargoed Until 12:01 a.m. EDT on March 26, 2012) –Cedars-Sinai researchers have determined that two prevalent drug therapies – rifaximin and lubiprostone – offer some of the best options for treating irritable bowel syndrome, a widespread disorder that affects up to one in five Americans. The findings, based on an analysis of more than two dozen large-scale clinical trials, are contained in a peer-reviewed study published online by The American Journal of Medicine and set to appear in the publication's April print edition.

Significant mismatch between PCI capable-hospitals and need

CHICAGO—There is an imbalance between the rapid growth of cardiac catheterization laboratories, which provide percutaneous coronary intervention (PCI) procedures, relative to the growth in the overall U.S. population, as well as patients who experience an acute heart attack, or ST-elevation myocardial infarction (STEMI), according to a study presented March 25 at the 61st annual American College of Cardiology (ACC) scientific session.

Diabetes associated with higher risk of cardiovascular problems in men

BOSTON, MA—According to a new study by researchers at Brigham and Women's Hospital (BWH), men with type 2 diabetes treated with insulin without a history of cardiovascular disease (CVD) were at higher risk for major cardiovascular events (e.g., death, heart attack, stroke) compared with men who had a history of CVD.

The study is being presented at the American College of Cardiology 2012 Annual Scientific Session, March 24 to 26 in Chicago.

Some 90-year-old heart attack patients have 'excellent' outcomes with coronary stenting

CHICAGO—Selected patients 90 years and older who experience an acute heart attack, or ST-elevation myocardial infarction (STEMI), have reasonable outcomes with coronary stenting, and should be considered for reperfusion therapy, based on a scientific poster being presented at the 61st annual American College of Cardiology (ACC) scientific session.

Current STEMI guidelines do not specifically address age-related reperfusion decisions, even number though the number of people over 90 years old in the U.S. is expected to quadruple by 2050.

Intervention results in increased use of evidence-based medications for patients with ACS

Among patients with acute coronary syndromes (such as heart attack or unstable angina) treated at public hospitals in Brazil, implementation of a multifaceted intervention that included educational materials, checklists and reminders resulted in improvement in the use of evidence-based medicines during the first 24 hours of hospitalization, according to a study appearing in JAMA. The study is being published early online to coincide with its presentation at the American College of Cardiology's annual scientific sessions.

Infusion of drug into the coronary artery may help reduce size of heart damage after heart attack

Administration of a bolus dose of the anticoagulant drug abciximab into the coronary artery involved in causing a certain type of heart attack among patients who were undergoing a percutaneous coronary intervention and also receiving another anticoagulant resulted in reduction in the size of damage to the heart muscle at 30 days, while a procedure that involved use of a catheter to remove the blood clot blocking that coronary artery did not produce these results, according to a study appearing in JAMA.

The long, err, short of it

BOSTON, MA—No one really wants the short end of the stick, in this case the short end of a chromosome. Telomeres, which are DNA-protein complexes at the ends of chromosomes, can be thought of as protein "caps" that protect chromosomes from deteriorating and fusing with neighboring chromosomes.

It is typical for telomeres to shorten as cells divide and chromosomes replicate over time. Now a new study from Brigham and Women's Hospital (BWH) suggest a strong link between telomere shortening and poor cardiovascular outcomes in patients with acute coronary syndrome.

Study examines treatment of heart failure with bone marrow cells

Use of a patient's bone marrow cells for treating chronic ischemic heart failure did not result in improvement on most measures of heart function, according to a study appearing in JAMA. The study is being published early online to coincide with its presentation at the American College of Cardiology's annual scientific sessions.

Cell therapy using patient's own bone marrow may present option for heart disease

CHICAGO— Cell therapy may present an option for patients with ischemic heart disease to use their own bone marrow cells to repair the damaged areas of their hearts, and may pave the way for future treatment options, according to the FOCUS trial, which will be presented as a late-breaking clinical trial March 24 at the 61st annual American College of Cardiology (ACC) scientific session.

Tears during coronary angioplasty: Where are they and how do they affect patient outcomes?

CHICAGO – Researchers from Thomas Jefferson University Hospital discovered that blockages in the right coronary artery and those in bending areas of the coronary artery are the most common places for dissection, a tear in the artery that can occur during balloon angioplasty of the coronary arteries.

They will present their findings at the American College of Cardiology annual meeting in Chicago on Saturday, March 24 at 9 AM.

Complications in patients undergoing PCI tend to occur within first 30 days

BOSTON, MA—Percutaneous coronary intervention (PCI), also known as coronary angioplasty or angioplasty, is a procedure used to treat acute coronary syndromes. PCI involves opening a blocked blood vessel by threading and inflating a balloon-tipped tube into the vessel. Sometimes a stent is also inserted to keep the blood vessel open.

While undergoing PCI treatment, doctors usually give patients medicine to prevent complications that may occur from the procedure.

Huge hamsters and pint-sized porcupines thrive on islands

DURHAM, N.C. -- From miniature elephants to monster mice, and even Hobbit-sized humans, size changes in island animals are well-known to science. Biologists have long believed that large animals evolving on islands tend to get smaller, while small animals tend to get bigger, a generalization they call "the island rule."

A new study by researchers at Duke University and the National Evolutionary Synthesis Center in Durham, NC puts that old idea to the test in island and mainland rodents.

In the final years of Franco's regime television acknowledged the republican's bravery

A study by the Complutense University of Madrid (UCM) into the development of speech about the Civil War on Television Española (Spain's national state owned public television broadcaster) states that from the 70's, public television stopped portraying republicans as national enemies and acknowledged their bravery as combatants.

Home alone -- depression highest for those living alone

The number of people living on their own has doubled, over the last three decades, to one in three in the UK and US. New research published in BioMed Central's open access journal BMC Public Health shows that the risk of depression, measured by people taking antidepressants, is almost 80% higher for those living alone compared to people living in any kind of social or family group.

How music prevents organ rejection

Music has a fundamental affect on humans. It can reduce stress, enhance relaxation, provide a distraction from pain, and improve the results of clinical therapy. New research published in BioMed Central's open access journal Journal of Cardiothoracic Surgery demonstrates that music can reduce rejection of heart transplants in mice by influencing the immune system.